NexImmune
Manufacturing · Maryland, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
9119 Gaither Rd, Gaithersburg, Maryland,...Phone Number
(301) 825-9810Website
www.neximmune.comRevenue
<$5 MillionStock Symbol
NEXIIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About NexImmune
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a product candidate targeted against HPV related cancers, which is in Phase I/II clinical trials. It provides NEXI-004 which is in preclinical stage for EBV related diseases; and NEXI005 designs for patient with specific targets for solid tumors. NexImmune, Inc. was incorporated in 2011 and is headRead more
NexImmune Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NexImmune your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when NexImmune launches new products
NexImmune, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if NexImmune is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on NexImmune recently announced quarterly report
Click to see if NexImmune had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once NexImmune has new funding data
Check if NexImmune has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at NexImmune
Recommended Actions
Reach out to Masked Content who joined NexImmune as Masked Content
Find 3 more new buyers
Compare Similar Companies to NexImmune
Compare insights from companies similar to NexImmune, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
NexImmune is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
NexImmune is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about NexImmune.
NexImmune financials insights
Gather financial insights about NexImmune, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Debt
$3M
2015
Debt
$2M
2017
Series A
$21.7M
2020
Debt
$350K
NexImmune Tech Stack
A closer look at the technologies used by NexImmune
See more technologies
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Left Company
Executive Move
Executive Moves, Left Company
Left Company
Executive Move
Executive Moves, Left Company
Executive Move
Executive Moves, Board of Directors
Left Company
Executive Move
Executive Moves, Left Company, Board of Directors
NexImmune News & Media
NexImmune Appoints Kristi Jones as Chief Executive Officer and Member of the Board of Directors
Detailed price information for Neximmune Inc (NEXI-Q) from The Globe and Mail including charting and trades.NexImmune Ends Stock Sale Agreement, Raises $5.1 Million - TipRanks.com
NexImmune (NEXI) has released an update to notify the public and investors about a termination of a material definitive agreement. NexImmune, Inc. had an agreement ...Why Is NexImmune (NEXI) Stock Down 10% Today? - InvestorPlace
NexImmune stock is falling on Monday as investors in NEXI continue to react to its plans to wind-down the business soon.Analyst Downgrades NexImmune After Going Back To Preclinical Stage
Latest Ratings for NEXI Date Firm Action From To Feb 2022 Raymond James Maintains Outperform Nov 2021 Raymond James Maintains Outperform Apr 2021 Raymond James Initiates Coverage On Outperform View More Analyst Ratings for NEXI View the Latest Analyst Ratings read more
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NexImmune
Sign Up For FreeTo access detailed company insights
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform... Read More
